JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M200270200 on March 23, 2002

J. Biol. Chem., Vol. 277, Issue 22, 19703-19708, May 31, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/22/19703    most recent
M200270200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wierzbicka-Patynowski, I.
Right arrow Articles by Schwarzbauer, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wierzbicka-Patynowski, I.
Right arrow Articles by Schwarzbauer, J. E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulatory Role for Src and Phosphatidylinositol 3-Kinase in Initiation of Fibronectin Matrix Assembly*

Iwona Wierzbicka-Patynowski and Jean E. SchwarzbauerDagger

From the Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544-1014

Received for publication, January 10, 2002, and in revised form, March 8, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Fibronectin (FN) matrix assembly is a tightly regulated stepwise process that is initiated by interactions between FN and cell surface integrin receptors. These interactions activate many intracellular signaling pathways that regulate processes such as cell adhesion, migration, and survival. Here we demonstrate that cells lacking Src family kinases showed reduced ability to assemble FN fibrils as detected by immunofluorescence and by analysis of detergent extracts. The amount of FN matrix was further reduced by treatment with the phosphatidylinositol 3 (PI 3-kinase) inhibitor, wortmannin. CHOalpha 5 cells, which are dependent on exogenous FN to initiate fibril formation, also showed significant reductions in matrix when treated with inhibitors of Src and PI 3-kinase. Combination of both inhibitors showed an additive inhibitory effect on assembly, which was concomitant with a loss of focal adhesion kinase phosphorylation. Decreased binding of the 70-kDa amino-terminal FN fragment at matrix assembly sites further supports a role for these kinases early during the process. We propose that these two signaling molecules, which lie downstream of integrins and focal adhesion kinase, are essential for efficient initiation of FN matrix assembly.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The extracellular matrix (ECM)1 surrounds cells and dynamically regulates cellular functions such as adhesion, migration, growth, and differentiation. Composition of the matrix varies from tissue to tissue; however, FN is a major component of most matrices (1, 2). FN influences diverse processes including inflammation, wound repair, malignant metastasis, microorganism attachment, and thrombosis. It does this not as a soluble protein but as a major component of a fibrillar network. FN is assembled into fibrils through a regulated stepwise process (3). The initiation of matrix assembly depends on interaction of FN with its cell surface receptor alpha 5beta 1 integrin. FN binding induces integrin interactions with the actin cytoskeleton inside the cell, whereas addition of FN dimers to growing multimers results in elongation of fibrils outside. Fibrils are then gradually converted into detergent-insoluble stable matrix.

Integrin-mediated interactions with FN-coated substrates induce reorganization of the actin cytoskeleton and associated proteins and lead to the formation of focal adhesions (4). These sites contain a multitude of cytoskeletal and adapter proteins such as vinculin, paxillin, and talin as well as signal transduction molecules such as focal adhesion kinase (FAK), Src family kinases, and protein kinase C. Many of these focal adhesion components are multidomain molecules that can interact with several distinct partners. Focal adhesions have been shown to serve both structural and functional roles as the sites where activation of intracellular pathways takes place. Some of these pathways have been implicated in FN matrix assembly. For example, treatment of fibroblasts with phorbol esters or other protein kinase C activators resulted in increased FN binding to the cell surface (5). An FN fragment containing the first type III repeat, which can modify FN matrix assembly (6, 7), activates ERK/MAP kinase signaling (8) and affects vascular smooth muscle cell proliferation (7, 9).

Interaction of FN with integrins also results in activation of FAK, which then binds to the signaling proteins Src (10, 11), PI 3-kinase (12), and the Grb7 adapter protein (13). Src associates with FAK through direct interaction of its Src homology (SH)2 domain with the major autophosphorylation site Tyr-397 on FAK. Association of Src with FAK is believed to be important for reciprocal activation of those two kinases (14). Furthermore, Src binding to FAK leads to phosphorylation of additional tyrosine residues on FAK that not only create new binding sites but also increase FAK catalytic activity (15). Src/FAK complex formation results in phosphorylation of other proteins such as paxillin, tensin, and p130cas. The Tyr-397 site on FAK also serves as a binding site for PI 3-kinase. Integrin-induced PI 3-kinase association with FAK has been demonstrated in platelets (16) and fibroblasts (17).

We have demonstrated previously that a mutant FN, which forms a structurally altered FN matrix, inhibited phosphorylation of FAK and blocked cell cycle progression (18). The role of signaling effectors downstream of FAK in the assembly of FN into fibrils has not been extensively studied. Here we investigated the requirement for active Src and PI 3-kinase in FN matrix assembly. We demonstrate that both Src and PI 3-kinase regulate early stages of matrix assembly, suggesting that FAK acts through multiple pathways to regulate matrix formation.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture-- SYF and SYFwtSrc cells were a kind gift from Dr. Philippe Soriano (Fred Hutchison Cancer Center, Seattle, WA). Cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf serum. CHOalpha 5 cells (19) were cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf serum (HyClone Laboratories), 2 mM glutamine, 1% nonessential amino acids, and 100 µg/ml Geneticin (Invitrogen). To prepare FN-depleted serum, fetal calf serum was passed over a gelatin-agarose column as described (20).

Reagents and Antibodies-- PP1 was a gift from Dr. Kevan Shokat (UCSF). Radicicol was obtained from Biomol (Plymouth Meeting, PA), wortmannin from Calbiochem, and LY294002 from Promega (Madison, WI). PT-66 anti-phosphotyrosine-specific monoclonal antibody was purchased from Sigma, and (anti-[Tyr(P)-577]FAK) antibody was purchased from BioSource International (Camarillo, CA).

Immunofluorescence Staining-- Cells were plated at 1.5 × 105 cells/well on 24-well plates with glass coverslips. SYF cells were allowed to attach for 1 h before the addition of FN, whereas CHOalpha 5 cells (which do not make FN) attached and spread overnight. Spread cells were then incubated with 25 µg/ml rat plasma FN (pFN). In some experiments, 5 µM PP1 and/or 100 nM wortmannin were added to the cells along with FN. After the desired incubation time, cells were fixed and stained with IC3 anti-rat FN monoclonal antibody (1:1,000 dilution) (19) followed by incubation with fluorescein-labeled goat anti-mouse IgG (Molecular Probes, Eugene, OR) (1:600 dilution) and rhodamine-phalloidin (Molecular Probes) (1:1,000 dilution). Coverslips were mounted with FluoroGuard Antifade reagent (Bio-Rad). Fibrils were visualized with a Nikon Optiphot microscope with epifluorescence. Images were captured using a CoolSNAP digital camera (RP Photometrics, Tucson, AZ).

Isolation and Detection of Deoxycholate-soluble and -insoluble Material-- Cells were plated at 1.5 × 105 cells/well on 24-well plates and incubated with 25 µg/ml rat pFN and/or inhibitors for indicated times using the same conditions as described for immunofluorescence staining. Deoxycholate-soluble and -insoluble fractions were isolated and analyzed as described previously (19). Total protein concentration was determined using BCA protein assay (Pierce). Equal amounts of total protein reduced with 0.1 M dithiothreitol were electrophoresed on 5% polyacrylamide SDS gel and transferred to nitrocellulose for immunodetection using a 1:10,000 dilution of IC3 anti-rat FN ascites fluid followed with 1:40,000 dilution of goat anti-mouse IgG-horseradish peroxidase-conjugated secondary antibody (Pierce). Immunoblots were developed with chemiluminescence reagents (Pierce).

Quantitation of Deoxycholate-insoluble Material-- Equal amounts of total protein from deoxycholate-insoluble fractions were separated by SDS-PAGE and transferred to nitrocellulose. After overnight incubation in blocking buffer (5% bovine serum albumin in Tris-buffered saline buffer (50 mM Tris-HCl, pH 7.5, 200 mM NaCl)), the membranes were incubated with a 1:10,000 dilution of IC3 monoclonal antibody for 1 h and then with 1 µg/ml unconjugated rabbit anti-mouse IgG (Pierce) for 1 h, both in blocking buffer. 6 µCi of 125I-protein A (specific activity 10 mCi/mg, ICN Pharmaceuticals, Costa Mesa, CA) in 10 ml of blocking buffer was then used for a 1-h incubation as described by Sechler et al. (19). The membranes were then exposed to a phosphor storage screen and analyzed using an Amersham Biosciences Storm 860. The amount of radioactivity associated with each band was measured. The number of counts for untreated cells was regarded as 100%. The number of counts for cells treated with inhibitors was calculated in comparison with untreated cells. Results are presented as the means ± S.E. of three independent experiments.

Analysis of Assembly Sites with Rhodamine-labeled 70-kDa Fragment-- Glass coverslips in 24-well plates were coated overnight with 10 µg/ml human pFN in PBS at 4 °C. Coverslips were washed with PBS, and 1 × 105 cells/well were placed in 500 µl of FN-depleted medium containing 25 µg/ml rhodamine-labeled 70-kDa fragment (Rh-70 kDa). The 70-kDa fragment of FN was prepared using the baculovirus expression system (21) and labeled with N-hydroxysuccinimide-rhodamine as suggested by the manufacturer (Pierce). Cells were incubated for 30 and 120 min in the presence or absence of 5 µM PP1, 100 nM wortmannin, or both inhibitors. After incubation cells were gently rinsed with PBS + 0.5 mM MgCl2 and fixed with fresh formaldehyde solution (3.7% in PBS) for 15 min at room temperature. Coverslips were mounted with FluoroGuard Antifade reagent (Bio-Rad). Rh-70 kDa rhodamine was visualized using a Nikon Optiphot microscope with epifluorescence. Images were captured using a CoolSNAP digital camera (RP Photometrics).

Tyrosine Phosphorylation-- Cells were plated at 1.2 × 105 cells/well on 24-well plates, allowed to attach and spread for ~2 h, and incubated in serum-depleted medium overnight. The cells then were incubated in complete medium in the presence of 25 µg/ml rat pFN for 15, 30, and 60 min. After incubation, cells were washed with cold PBS and lysed with 200 µl of modified radioimmune precipitation buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 1% Triton, 1% Na-deoxycholate, 0.1% SDS). 1 mM EGTA, 1 mM Na3VO4, 10 mM Na4P2O7, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, and 100 units/ml aprotinin were used as different enzyme inhibitors. Cell lysates were centrifuged at 4 °C for 15 min at 14,000 rpm. Supernatant was collected, and total protein concentration was determined using BCA protein assay (Pierce). 2 µg of total protein reduced with 0.1 M dithiothreitol was resolved by 7% polyacrylamide SDS gel and transferred to nitrocellulose. Immunoblot analysis was performed as for the deoxycholate lysates except a 1:3,300 dilution of PT-66 anti-phosphotyrosine antibody was used.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Decreased FN Matrix on Cells Lacking Src Family Kinases-- SYF fibroblasts lacking three Src family kinases (Src, Yes, and Fyn) display no Src-related kinase activity but will attach and spread on FN-coated substrates (22). To examine the requirement for Src kinases in integrin-mediated assembly of FN matrix, assembly of FN fibrils was monitored by immunofluorescence. SYF cells were compared with SYFwtSrc cells, which are SYF cells transfected with wtSrc cDNA. Exogenous rat pFN was included in the medium to ensure a sufficient supply of FN. Both cell lines assembled FN into a fibrillar matrix; however, SYFwtSrc cells appeared to assemble more matrix than SYF cells (Fig. 1). Analysis of deoxycholate-insoluble matrix fractions showed that over a 5-h period SYF cells assembled significantly less matrix than SYFwtSrc cells (Fig. 2A). Very early time points were examined to determine the ability of these cells to initiate assembly. To enhance our ability to examine assembly at early times, chemiluminescence exposures were increased for samples from shorter time points. A difference was detected at the earliest time point, 15 min after adding FN to the medium (Fig. 2B). SYFwtSrc cells produced detectable FN matrix by this time, whereas SYF cells showed very little FN matrix (even 30 min after addition of FN). This delayed assembly of FN matrix by SYF cells suggests that Src family kinases may regulate the early stages of FN matrix assembly.


View larger version (63K):
[in this window]
[in a new window]
  		Fig. 1.   Immunofluorescence staining of FN matrix. SYF and SYFwtSrc cells were incubated with 25 µg/ml pFN for 2 h. Fibrils were detected by indirect immunofluorescence using rat-specific monoclonal antibody IC3 and fluorescein-conjugated goat anti-mouse IgG.


View larger version (60K):
[in this window]
[in a new window]
  		Fig. 2.   Analysis of deoxycholate-insoluble FN matrix. SYF and SYFwtSrc cells were incubated with 25 µg/ml pFN for 1, 3, and 5 h (A) or 15, 30, 60, and 120 min (B). The cells were then lysed with deoxycholate lysis buffer, and equal amounts of total protein were separated by 5% SDS-PAGE and transferred to nitrocellulose. FN was detected using rat-specific monoclonal antibody IC3 followed by horseradish peroxidase-conjugated goat anti-mouse IgG and chemiluminescence reagents.

PI 3-Kinase Participates in FN Matrix Assembly-- Products of PI 3-kinase activity such as PIP2 are involved in integrin-related processes, and PI 3-kinase itself acts to integrate multiple pathways downstream of integrins (23-25). We therefore tested the requirement for active PI 3-kinase in SYF cells. SYF cells were incubated with FN in the presence of wortmannin, a PI 3-kinase inhibitor (26). As shown in Fig. 3A, wortmannin treatment resulted in almost complete inhibition of deoxycholate-insoluble FN matrix formation. No major effects of wortmannin on actin stress fibers were observed (Fig. 3B). These results show that together functional Src kinases and PI 3-kinase play a regulatory role in matrix formation by acting to enhance initiation of FN fibril assembly. A third pathway downstream of integrins leads to ERK/MAP kinase activation. Inhibition of this pathway with the MEK1 inhibitor PD98059 had no effect on initiation of fibril formation (data not shown).


View larger version (82K):
[in this window]
[in a new window]
  		Fig. 3.   Wortmannin inhibits FN matrix assembly by SYF cells. SYF cells were incubated with 25 µg/ml pFN in the presence or absence of wortmannin (WRT, 100 nM) for the indicated time (in min). A, lysates were prepared and analyzed as described in the legend to Fig. 2; B, actin stress fibers in cells incubated for 2 h were detected by direct fluorescence microscopy using rhodamine-phalloidin.

Src and PI 3-Kinase Are Required for Assembly in CHO Cells-- SYF cells produce endogenous FN, which makes it difficult to control the timing of assembly by addition of FN. Therefore, we used CHO cells transfected with human alpha 5 cDNA (CHOalpha 5 cells) (19) because these cells lack an endogenous FN matrix but are capable of assembling a matrix when provided with exogenous FN. CHOalpha 5 cells were allowed to attach overnight and were then incubated in fresh medium containing 25 µg/ml rat pFN plus the Src inhibitor PP1 (27). CHOalpha 5 cells in the absence of PP1 assembled an extensive matrix between and on top of the cells (Fig. 4A). In contrast, cells incubated with PP1 formed less matrix, with fibrils mainly between cells even after 6 h of incubation (Fig. 4A). A dramatic difference in deoxycholate-insoluble material was also observed at times up to 6 h (Fig. 4B). Treatment of CHOalpha 5 cells with another Src inhibitor, radicicol (28), also inhibited FN matrix assembly similarly to PP1 (data not shown).


View larger version (86K):
[in this window]
[in a new window]
  		Fig. 4.   PP1 inhibits FN matrix assembly by CHOalpha 5 cells. CHOalpha 5 cells were incubated with 25 µg/ml pFN in the presence or absence of 5 µM PP1 Src inhibitor for 1 and 6 h. FN matrix was examined by immunofluorescence staining of FN fibrils (6 h) (A) and by biochemical analysis of deoxycholate-insoluble fractions as described in the legend to Fig. 2 (B).

Similar to SYF cells, assembly was perturbed at a very early stage with reduced deoxycholate-insoluble material observed as early as 30 min (Fig. 5A). This process was also inhibited by wortmannin, although the level of inhibition appeared lower than with PP1 (Fig. 5A). Addition of Src and PI 3-kinase inhibitors together resulted in almost complete inhibition of FN matrix assembly over a 2-h incubation. No major effects of these inhibitors on actin stress fibers were noted (Fig. 5C). The effect of LY294002, another PI 3-kinase inhibitor (29), on FN matrix assembly was identical to that of wortmannin (data not shown).


View larger version (39K):
[in this window]
[in a new window]
  		Fig. 5.   Combined effect of PP1 and wortmannin on FN matrix assembly. A, analysis of deoxycholate-insoluble fractions of CHOalpha 5 cells incubated with 5 µM PP1, 100 nM wortmannin (WRT), or both inhibitors. Deoxycholate lysates were analyzed as described in the legend to Fig. 2. B, FN levels in deoxycholate-insoluble fractions of cells incubated with 5 µM PP1, 100 nM wortmannin, or both inhibitors were quantitated. The amount of FN was detected in immunoblots using rat-specific monoclonal antibody IC3 followed by rabbit anti-mouse IgG and 125I-protein A. Membranes were then exposed to a phosphor storage screen. The amount of radioactivity associated with each band was measured. The number of counts for untreated cells was regarded as 100%. The number of counts for cells treated with inhibitors was calculated in comparison with untreated cells. Each bar represents the means ± S.E. of three independent experiments. Gray bar, untreated; stippled bar, PP1-treated; crossed bar, wortmannin-treated; white bar, PP1- and wortmannin-treated). C, fluorescence analysis of actin stress fibers stained with rhodamine-phalloidin in CHOalpha 5 cells untreated or incubated for 2 h with 5 µM PP1 and 100 nM wortmannin.

In combination, inhibition of Src and PI 3-kinase caused a dramatic decrease in the amount of FN matrix. Quantitation of deoxycholate-insoluble fractions revealed that during 2 h of assembly both inhibitors together reduced matrix to about one-quarter of the control level (Fig. 5B). This level of inhibition was twice as high as when either inhibitor was added alone, suggesting that the combined effects of Src and PI 3-kinase on FN matrix assembly are additive. We also observed that after only 1 h the effect of wortmannin was much less than that of PP1, suggesting that Src may affect matrix formation earlier than PI 3-kinase (not shown).

Src and PI 3-Kinase Affect the Formation of Matrix Assembly Sites-- FN assembly into fibrils is a stepwise process that is initiated through alpha 5beta 1 integrin binding to FN. Clustering of receptors promotes fibrillogenesis, which requires FN-FN interactions mediated by the amino-terminal domain and multimerization of FN dimers into fibrils (30). The 70-kDa amino-terminal fragment of FN (which contains a FN self-association site) can be used to identify sites of assembly within the matrix (6, 31). 70-kDa fragment binding is dependent on interactions with intact FN immobilized within newly formed matrix fibrils (32).

To determine whether Src and PI 3-kinase activities are required for formation of matrix assembly sites, the presence of these sites was detected with rhodamine-labeled 70-kDa fragment (Rh-70 kDa). CHOalpha 5 cells were plated on FN-coated glass coverslips in medium containing Rh-70 kDa and in the presence or absence of PP1, wortmannin, or both inhibitors. CHOalpha 5 cells reorganized the surface-coated FN into short fibrils that generated binding sites for Rh-70 kDa within 30 min with more extensive incorporation by 2 h (Fig. 6, A and A'). PP1 (Fig. 6, B and B') and wortmannin (Fig. 6, C and C') alone inhibited formation of Rh-70 kDa binding sites. The inhibitory effects were strongest, however, when PP1 and wortmannin were used in combination (Fig. 6, D and D'). These results demonstrate that active Src and PI 3-kinase are required for formation of FN matrix assembly sites and indicate that these enzymes regulate initiation of FN fibril assembly.


View larger version (22K):
[in this window]
[in a new window]
  		Fig. 6.   Incorporation of Rh-70 kDa fragment of FN at matrix assembly sites. CHOalpha 5 cells were plated on FN-coated glass coverslips and incubated with 25 µg/ml Rh-70 kDa in the absence (A and A') or presence of 5 µM PP1 (B and B'), 100 nM wortmannin (WRT) (C and C'), or both (D and D') for 30 min (A-D) or 2 h (A'-D'). Cells were then fixed and mounted for visualization of Rh-70 kDa with a Nikon Optiphot microscope with epifluorescence.

Correlation of Src and PI 3-Kinase Activity with FAK Phosphorylation-- Both PI 3-kinase and Src family kinases interact with FAK and are involved in activation of downstream pathways. SYF cells plated on FN-coated substrate do not show FAK phosphorylation (22). To determine whether FAK activation correlates with FN matrix assembly, levels of FAK phosphorylation were analyzed. SYF cells showed no detectable FAK phosphorylation during the time course of this experiment (Fig. 7). In contrast, significant levels of FAK phosphorylation were observed in SYFwtSrc cells during the same period. Identical results were obtained when FAK phosphorylation was detected using FAK Tyr-577 phosphospecific antibody (anti-[Tyr(P)-577]FAK) (data not shown). Perturbation in FAK phosphorylation correlates with the timing of reduced FN assembly. Interestingly, FAK-null fibroblasts show very little detectable deoxycholate-insoluble FN matrix.2 Taken together, these results suggest that stimulation of Src and PI 3-kinase by FAK is required for efficient initiation of FN matrix assembly.


View larger version (49K):
[in this window]
[in a new window]
  		Fig. 7.   Tyrosine phosphorylation of FAK. SYF and SYFwtSrc cells were serum-starved and incubated with 25 µg/ml pFN for the indicated time (min). Equal amounts of total protein in cell lysates were separated by 7% SDS-PAGE and transferred to nitrocellulose. Tyrosine phosphorylation of FAK was detected using PT-66 anti-phosphotyrosine antibody and chemiluminescence reagents.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this report, we show using two different cell systems that inhibition of Src by mutation of Src family kinase genes in SYF cells or with Src-specific inhibitors in CHOalpha 5 cells results in significant reduction of FN matrix assembly. A further reduction in matrix was seen with concomitant inhibition of PI 3-kinase activity. The major effects of blocking kinase action occurred early during fibril formation and could be demonstrated by detergent insolubility as well as by monitoring development of matrix assembly sites with 70-kDa binding. Both Src and PI 3-kinase lie immediately downstream of FAK. Inhibition of MAP kinase signaling, a third pathway downstream of FAK, had no effect on initiation of fibril formation. Therefore, we propose that a subset of signaling pathways activated by FAK are essential for proper initiation of FN matrix assembly.

Src family kinases govern many cellular functions such as growth factor-induced proliferation and gene expression, ECM-promoted adhesion, spreading, migration, and protection from apoptosis (33-36). Mutation of three ubiquitous members (Src, Yes, and Fyn) leads to severe developmental defects and lethality by mid-gestation. Interestingly, the SYF triple mutant embryonic defects resemble those of FN-null embryos, suggesting overlapping functions during development (22, 37). SYF cells are able to adhere to FN substrata but show dramatically reduced FN-dependent tyrosine phosphorylation (22). Similarly, we found that FAK phosphorylation was ablated in SYF cells during matrix assembly and that this reduction in phosphorylation correlated with decreased fibril formation. In contrast, SYF cells overexpressing c-Src showed FN-induced tyrosine phosphorylation of focal adhesion proteins (including FAK) as well as normal levels of FN fibrils. These findings provide evidence for a link between Src kinase activity and FN matrix assembly.

PI 3-kinase phosphorylates phosphatidylinositol and together with its lipid derivatives acts as a second messenger in a variety of signaling pathways including cell survival through activation of PKB/Akt (23, 38-40) and cell migration (24, 25, 41, 42). PI 3-kinase binds to the same site on FAK as Src does (12) and has been shown to associate with FAK upon integrin activation in platelets (16) and fibroblasts (17). Our results indicate that PI 3-kinase also regulates FN fibril formation. In combination, inhibition of both Src and PI 3-kinase dramatically reduced FN matrix assembly. At 2 h the effect was twice as potent as with either inhibitor used alone, suggesting that the effects are additive. Interestingly, however, we consistently observed that Src activity was required at the earliest times tested, although PI 3-kinase inhibition had its major impact after 2 h. This suggests that although both kinases participate in this process, their roles are not identical.

A major mechanism of activation of Src and PI 3-kinase is through binding to phosphorylated FAK in response to integrin ligation by FN (43-45). FAK itself has been implicated in regulatory responses to FN matrix in that alterations in FN matrix structure modulate the level of FAK tyrosine phosphorylation (18). In addition, FAK-null cells show a dramatically reduced ability to assemble FN matrix3 although the ability to attach to immobilized FN is only slightly impaired (46). One plausible model for regulation of integrin-mediated FN fibril initiation is that active FAK recruits Src and PI 3-kinase, which in turn transduce downstream signals required to initiate and maintain propagation of FN fibrils. Inhibition of any one of these kinases, either through mutation or with specific inhibitors, reduces the extent of fibril formation. There is evidence that association of Src with FAK may further stimulate both kinases (14). Similarly, the inhibition of PI 3-kinase leads to partial inhibition of FAK tyrosine phosphorylation in COS7 cells (23). These observations suggest that there may be a feedback loop between FAK, Src, and PI 3-kinase that results in mutual activation of these signaling components through direct interactions. Both Src and PI 3-kinase bind to phosphorylated Tyr-397 on FAK, presenting an attractive idea that cells require phosphorylation of this tyrosine to regulate matrix assembly.

The initial interaction of FN dimers with cell surface receptors leads to receptor clustering, which not only promotes FN self-association but also connects FN to the actin cytoskeleton. Both an intact cytoskeleton and the beta  integrin cytoplasmic domain are required for FN matrix assembly (47, 48). Choquet et al. (49) showed that initial connections between FN, alpha 5beta 1 integrin, and actin filaments are relatively weak in adherent cells but become reinforced in response to applied force. This strengthening mechanism appears to require phosphoproteins, although the specific components have not been reported. It seems likely that reinforcement of cell-FN connections is also required during fibril assembly. FAK, Src, and/or PI 3-kinase may contribute to reinforcement of transmembrane connections because integrins assemble FN fibrils and may thus represent some of the necessary phosphoproteins. We did not observe any major effects of Src and PI 3-kinase inhibitors on actin stress fibers, but it remains possible that these kinases exert effects by strengthening existing links between integrins and actin.

The deposition of FN into the ECM is a complex, integrin-dependent, and highly regulated process. The ECM has important effects on cell morphology, growth, and gene expression. Defects in matrix organization contribute to disease and developmental defects. Therefore, it is important to understand regulation of FN matrix formation. The data presented here demonstrate that Src and PI 3-kinase, two downstream effectors of FAK, are important in this regulation, particularly during initiation. Assembly is a multistep process, and other signaling molecules have been implicated in both early and late stages, further demonstrating the complexities of regulating FN fibril formation. It remains possible that other signaling molecules downstream of FAK, such as Grb7 (50) or the gamma 1 isoform of phospholipase C (51), may also participate. Clearly, further investigation is needed to sort out the intracellular components that control each step of FN matrix assembly.

    ACKNOWLEDGEMENTS

We thank Drs. Hisaaki Kawakatsu and Dusko Ilic from UCSF for helpful discussions and Nedra Guckert for technical assistance.

    FOOTNOTES

* This work was supported by National Institutes of Health Training Grants T32 CA09528-16 (to I. W.-P.) and R01 GM 59383 (to J. E. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 609-258-2893; Fax: 609-258-1035; E-mail: jschwarzbauer@molbio.princeton.edu.

Published, JBC Papers in Press, March 23, 2002, DOI 10.1074/jbc.M200270200

2 D. Ilic and C. Damsky, manuscript in preparation.

3 D. Ilic and C. Damsky, manuscript in preparation; I. Wierzbicka-Patynowski, unpublished data.

    ABBREVIATIONS

The abbreviations used are: ECM, extracellular matrix; FN, fibronectin; PI 3-kinase, phosphatidylinositol 3-kinase; CHO, Chinese hamster ovary; FAK, focal adhesion kinase; SYF cells, cells lacking Src family kinases; Rh-70 kDa, rhodamine-labeled 70-kDa fragment; PBS, phosphate-buffered saline; pFN, plasma FN; MAP, mitogen-activated protein; MEK, MAP kinase; ERK, extracellular signal-regulated kinase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Mosher, D. F. (ed) (1989) Fibronectin , Academic Press, New York
2. Hynes, R. O. (1990) Fibronectins , Springer-Verlag, New York
3. Schwarzbauer, J. E., and Sechler, J. L. (1999) Curr. Opin. Cell Biol. 11, 622-627[CrossRef][Medline] [Order article via Infotrieve]
4. Geiger, B., Bershadsky, A., Pankov, R., and Yamada, K. M. (2001) Nat. Rev. Mol. Cell. Biol. 2, 793-805[CrossRef][Medline] [Order article via Infotrieve]
5. Somers, C. E., and Mosher, D. F. (1993) J. Biol. Chem. 268, 22277-22280[Abstract/Free Full Text]
6. Hocking, D. C., Smith, R. K., and McKeown-Longo, P. J. (1996) J. Cell Biol. 133, 431-444[Abstract/Free Full Text]
7. Mercurius, K. O., and Morla, A. O. (1998) Circ. Res. 82, 548-556[Abstract/Free Full Text]
8. Mercurius, K. O., and Morla, A. O. (2001) BMC Cell Biol. 2, 18-30[CrossRef][Medline] [Order article via Infotrieve]
9. Bourdoulous, S., Orend, G., MacKenna, D. A., Pasqualini, R., and Ruoslahti, E. (1998) J. Cell Biol. 143, 267-276[Abstract/Free Full Text]
10. Schaller, M. D., and Parsons, J. T. (1994) Curr. Opin. Cell Biol. 6, 705-710[CrossRef][Medline] [Order article via Infotrieve]
11. Xing, Z., Chen, H. C., Nowlen, J. K., Taylor, S. J., Shalloway, D., and Guan, J. L. (1994) Mol. Biol. Cell 5, 413-421[Abstract]
12. Chen, H. C., Appeddu, P. A., Isoda, H., and Guan, J. L. (1996) J. Biol. Chem. 271, 26329-26334[Abstract/Free Full Text]
13. Han, D. C., and Guan, J. L. (1999) J. Biol. Chem. 274, 24425-24430[Abstract/Free Full Text]
14. Guan, J. L. (1997) Int. J. Biochem. Cell Biol. 29, 1085-1096[CrossRef][Medline] [Order article via Infotrieve]
15. Calalb, M. B., Polte, T. R., and Hanks, S. K. (1995) Mol. Cell. Biol. 15, 954-963[Abstract]
16. Guinebault, C., Payrastre, B., Racaud-Sultan, C., Mazarguil, H., Breton, M., Mauco, G., Plantavid, M., and Chap, H. (1995) J. Cell Biol. 129, 831-842[Abstract/Free Full Text]
17. Chen, H. C., and Guan, J. L. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 10148-10152[Abstract/Free Full Text]
18. Sechler, J. L., and Schwarzbauer, J. E. (1998) J. Biol. Chem. 273, 25533-25536[Abstract/Free Full Text]
19. Sechler, J. L., Takada, Y., and Schwarzbauer, J. E. (1996) J. Cell Biol. 134, 573-583[Abstract/Free Full Text]
20. Engvall, E., and Ruoslahti, E. (1977) Int. J. Cancer 20, 1-5[Medline] [Order article via Infotrieve]
21. Aguirre, K. M., McCormick, R. J., and Schwarzbauer, J. E. (1994) J. Biol. Chem. 269, 27863-27868[Abstract/Free Full Text]
22. Klinghoffer, R. A., Sachsenmaier, C., Cooper, J. A., and Soriano, P. (1999) EMBO J. 18, 2459-2471[CrossRef][Medline] [Order article via Infotrieve]
23. King, W. G., Mattaliano, M. D., Chan, T. O., Tsichlis, P. N., and Brugge, J. S. (1997) Mol. Cell. Biol. 17, 4406-4418[Abstract]
24. Shaw, L. M., Rabinovitz, I., Wang, H. H., Toker, A., and Mercurio, A. M. (1997) Cell 91, 949-960[CrossRef][Medline] [Order article via Infotrieve]
25. Reiske, H. R., Kao, S. C., Cary, L. A., Guan, J. L., Lai, J. F., and Chen, H. C. (1999) J. Biol. Chem. 274, 12361-12366[Abstract/Free Full Text]
26. Wymann, M. P., Bulgarelli-Leva, G., Zvelebil, M. J., Pirola, L., Vanhaesebroeck, B., Waterfield, M. D., and Panayotou, G. (1996) Mol. Cell. Biol. 16, 1722-1733[Abstract]
27. Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., and Connelly, P. A. (1996) J. Biol. Chem. 271, 695-701[Abstract/Free Full Text]
28. Kwon, H. J., Yoshida, M., Fukui, Y., Horinouchi, S., and Beppu, T. (1992) Cancer Res. 52, 6926-6930[Abstract/Free Full Text]
29. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. (1994) J. Biol. Chem. 269, 5241-5248[Abstract/Free Full Text]
30. Schwarzbauer, J. E. (1991) J. Cell Biol. 113, 1463-1473[Abstract/Free Full Text]
31. Dzamba, B. J., Bultmann, H., Akiyama, S. K., and Peters, D. M. (1994) J. Biol. Chem. 269, 19646-19652[Abstract/Free Full Text]
32. Sottile, J., and Wiley, S. (1994) J. Biol. Chem. 269, 17192-17198[Abstract/Free Full Text]
33. Brown, M. T., and Cooper, J. A. (1996) Biochim. Biophys. Acta 1287, 121-149[Medline] [Order article via Infotrieve]
34. Lowell, C. A., and Soriano, P. (1996) Genes Dev. 10, 1845-1857[Free Full Text]
35. Parsons, J. T., and Parsons, S. J. (1997) Curr. Opin. Cell Biol. 9, 187-192[CrossRef][Medline] [Order article via Infotrieve]
36. Thomas, S. M., and Brugge, J. S. (1997) Annu. Rev. Cell Dev. Biol. 13, 513-609[CrossRef][Medline] [Order article via Infotrieve]
37. George, E. L., Georges-Labouesse, E. N., Patel-King, R. S., Rayburn, H., and Hynes, R. O. (1993) Development 119, 1079-1091[Abstract]
38. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H., and Downward, J. (1997) EMBO J. 16, 2783-2793[CrossRef][Medline] [Order article via Infotrieve]
39. Frisch, S. M., Vuori, K., Kelaita, D., and Sicks, S. (1996) J. Cell Biol. 135, 1377-1382[Abstract/Free Full Text]
40. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N., and Hay, N. (1997) Genes Dev. 11, 701-713[Abstract/Free Full Text]
41. Kundra, V., Escobedo, J. A., Kazlauskas, A., Kim, H. K., Rhee, S. G., Williams, L. T., and Zetter, B. R. (1994) Nature 367, 474-476[CrossRef][Medline] [Order article via Infotrieve]
42. Wennstrom, S., Siegbahn, A., Yokote, K., Arvidsson, A. K., Heldin, C. H., Mori, S., and Claesson-Welsh, L. (1994) Oncogene 9, 651-660[Medline] [Order article via Infotrieve]
43. Schwartz, M. A. (2001) Trends Cell Biol. 11, 466-470[CrossRef][Medline] [Order article via Infotrieve]
44. Zhao, J. H., and Guan, J. L. (2000) Prog. Mol. Subcell. Biol. 25, 37-55[Medline] [Order article via Infotrieve]
45. Shen, T. L., and Guan, J. L. (2001) FEBS Lett. 499, 176-181[CrossRef][Medline] [Order article via Infotrieve]
46. Ilic, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., and Yamamoto, T. (1995) Nature 377, 539-544[CrossRef][Medline] [Order article via Infotrieve]
47. Solowska, J., Guan, J. L., Marcantonio, E. E., Trevithick, J. E., Buck, C. A., and Hynes, R. O. (1989) J. Cell Biol. 109, 853-861[Abstract/Free Full Text]
48. Wu, C., Kevins, V., O'Toole, T. E., McDonald, J. A., and Ginsberg, M. H. (1995) Cell 83, 715-724[CrossRef][Medline] [Order article via Infotrieve]
49. Choquet, D., Felsenfeld, D. P., and Sheetz, M. P. (1997) Cell 88, 39-48[CrossRef][Medline] [Order article via Infotrieve]
50. Han, D. C., Shen, T. L., and Guan, J. L. (2000) J. Biol. Chem. 275, 28911-28917[Abstract/Free Full Text]
51. Zhang, X., Chattopadhyay, A., Ji, Q. S., Owen, J. D., Ruest, P. J., Carpenter, G., and Hanks, S. K. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 9021-9026[Abstract/Free Full Text]

Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JCBHome page
C. C. Feral, A. Zijlstra, E. Tkachenko, G. Prager, M. L. Gardel, M. Slepak, and M. H. Ginsberg
CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling
J. Cell Biol., August 9, 2007; 178(4): 701 - 711.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. R. Somanath, E. S. Kandel, N. Hay, and T. V. Byzova
Akt1 Signaling Regulates Integrin Activation, Matrix Recognition, and Fibronectin Assembly
J. Biol. Chem., August 3, 2007; 282(31): 22964 - 22976.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
A. Yoneda, D. Ushakov, H. A.B. Multhaupt, and J. R. Couchman
Fibronectin Matrix Assembly Requires Distinct Contributions from Rho Kinases I and -II
Mol. Biol. Cell, January 1, 2007; 18(1): 66 - 75.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
B. S. Winters, B. K. M. Raj, E. E. Robinson, R. A. Foty, and S. A. Corbett
Three-dimensional Culture Regulates Raf-1 Expression to Modulate Fibronectin Matrix Assembly
Mol. Biol. Cell, August 1, 2006; 17(8): 3386 - 3396.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. Lagana, J. G. Goetz, P. Cheung, A. Raz, J. W. Dennis, and I. R. Nabi
Galectin Binding to Mgat5-Modified N-Glycans Regulates Fibronectin Matrix Remodeling in Tumor Cells
Mol. Cell. Biol., April 15, 2006; 26(8): 3181 - 3193.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
L. H. Romer, K. G. Birukov, and J. G.N. Garcia
Focal Adhesions: Paradigm for a Signaling Nexus
Circ. Res., March 17, 2006; 98(5): 606 - 616.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
Y. Mao and J. E. Schwarzbauer
Stimulatory effects of a three-dimensional microenvironment on cell-mediated fibronectin fibrillogenesis
J. Cell Sci., October 1, 2005; 118(19): 4427 - 4436.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. K. Y. Siu, C.-h. Wong, W. M. Lee, and C. Y. Cheng
Sertoli-Germ Cell Anchoring Junction Dynamics in the Testis Are Regulated by an Interplay of Lipid and Protein Kinases
J. Biol. Chem., July 1, 2005; 280(26): 25029 - 25047.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. C. Krepinsky, Y. Li, Y. Chang, L. Liu, F. Peng, D. Wu, D. Tang, J. Scholey, and A. J. Ingram
Akt Mediates Mechanical Strain-Induced Collagen Production by Mesangial Cells
J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1661 - 1672.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
K. S. Midwood, L. V. Valenick, H. C. Hsia, and J. E. Schwarzbauer
Coregulation of Fibronectin Signaling and Matrix Contraction by Tenascin-C and Syndecan-4
Mol. Biol. Cell, December 1, 2004; 15(12): 5670 - 5677.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Bae, T. Sakai, and D. F. Mosher
Assembly of Exogenous Fibronectin by Fibronectin-null Cells Is Dependent on the Adhesive Substrate
J. Biol. Chem., August 20, 2004; 279(34): 35749 - 35759.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
M. K.Y. Siu and C. Y. Cheng
Extracellular Matrix: Recent Advances on Its Role in Junction Dynamics in the Seminiferous Epithelium During Spermatogenesis
Biol Reprod, August 1, 2004; 71(2): 375 - 391.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
D. Ilic, B. Kovacic, K. Johkura, D. D. Schlaepfer, N. Tomasevic, Q. Han, J.-B. Kim, K. Howerton, C. Baumbusch, N. Ogiwara, et al.
FAK promotes organization of fibronectin matrix and fibrillar adhesions
J. Cell Sci., January 15, 2004; 117(2): 177 - 187.